Streetbeat News

Products Services

EVBG

Everbridge, Inc. (NASDAQ:EVBG) has been selected to power the Public Alert Notification System (PANS) for Trinidad and Tobago, providing emergency alert information to the country's 1.4 million residents and visitors. The system was launched ahead of the 2023 Atlantic Hurricane Season.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:28 pm

MSFT

NVDA

UBER

Uber rival Bolt Technology partners with Starship Technologies to use AI robots for food delivery starting in 2023. The deal will see thousands of robots handling Bolt Food orders across multiple countries.

Portfolio Pulse from Anusuya Lahiri

June 21, 2023 | 12:25 pm

NFLX

WBD

Warner Bros. Discovery is in talks to license some of its HBO library titles, including Issa Rae's comedy Insecure, to rival Netflix. This marks a major strategy shift and could boost Warner Bros. Discovery's bottom line.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:25 pm

QURE

uniQure announced interim data from the Phase I/II trial of AMT-130 in Huntington's Disease, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:24 pm

BMRA

Biomerica Inc. (NASDAQ:BMRA) has received a Notice of Allowance from the China National Intellectual Property Administration for a patent application covering an AI-based system to predict and prevent adverse food reactions using personal medical data. The patent strengthens the company's intellectual property portfolio in science, diet, and technology.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:24 pm

MYNA

RTX

Mynaric has been selected by Raytheon Technologies to supply optical communications terminals for the Space Development Agency (SDA) Tranche 1 Tracking Layer program. Mynaric will supply 21 CONDOR Mk3 terminals to Raytheon, with product deliveries expected in 2024.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:22 pm

OCEA

Ocean Biomedical's share price target has been increased to $17.63 by Fundamental Research Corp. (FRC) following positive results from an independent study on glioblastoma tumor suppression, new patents, and recent financing. FRC's report highlights Ocean Biomedical's diversified development pipeline, which includes drug candidates for oncology, fibrosis, and infectious diseases.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:20 pm

DARE

Daré Bioscience announced the publication of data from a Phase 1/2 clinical trial of DARE-HRT1, a potential first FDA-approved monthly intravaginal ring for hormone therapy. The company plans to advance DARE-HRT1 into a single Phase 3 clinical trial for the treatment of vasomotor symptoms due to menopause.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:19 pm

OCUP

Ocuphire Pharma announced that Dr. Victor H. Gonzalez will present late breaking clinical data on APX3330 ZETA-1 at the American Diabetes Association Annual Conference. The presentation will focus on the efficacy and safety results of the ZETA-1 Phase 2 trial in diabetic retinopathy.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:18 pm

BWAY

BrainsWay Ltd. announced a significant expansion of its technology platform with an order of 30 new Deep Transcranial Magnetic Stimulation (Deep TMS) systems for the treatment of major depressive disorder (MDD) by a large TMS network of clinics in the Western and Central United States. Several systems also include an H7 Coil for obsessive-compulsive disorder (OCD) treatment.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:17 pm